| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/22/2011 | US20110229559 Drug Release From Nanoparticle-Coated Capsules |
| 09/22/2011 | US20110229558 Agent for treating myelofibrosis |
| 09/22/2011 | US20110229557 Methods for treating eye disorders |
| 09/22/2011 | US20110229556 Lipid-coated polymer particles for immune stimulation |
| 09/22/2011 | US20110229555 Intravenous curcumin and derivatives for treatment of neurodegenerative and stress disorders |
| 09/22/2011 | US20110229554 INTRAVENOUS FORMULATIONS OF COENZYME Q10 (CoQ10) AND METHODS OF USE THEREOF |
| 09/22/2011 | US20110229553 Plant Extract with Pharmacological Profile for Treating or Preventing Diseases, Dysfunctions and Disorders of the Central Nervous System, Neurodegenerative Disorders and Sequel from Vascular Dementia |
| 09/22/2011 | US20110229552 NOVEL mRNA SPLICE VARIANT OF THE DOUBLECORTIN-LIKE KINASE GENE AND ITS USE IN DIAGNOSIS AND THERAPY OF CANCERS OF NEUROECTODERMAL ORIGIN |
| 09/22/2011 | US20110229551 Drug delivery compositions and methods using nanofiber webs |
| 09/22/2011 | US20110229550 Acid-Degradable and Bioerodible Modified Polyhydroxylated Materials |
| 09/22/2011 | US20110229549 Methods and Compositions for Enhancing Vascular Access |
| 09/22/2011 | US20110229546 Treatment of dissection, aneurysm, and atherosclerosis using granzyme b inhibitors |
| 09/22/2011 | US20110229545 Melt emulsification |
| 09/22/2011 | US20110229539 Chewing gum possessing tooth cleaning effect and a teeth cleaning method |
| 09/22/2011 | US20110229536 Compositions for topical application comprising microencapsulated colorants |
| 09/22/2011 | US20110229535 Composition having a sirtuin activator |
| 09/22/2011 | US20110229534 Non-Irritating Oral Care Formulations |
| 09/22/2011 | US20110229533 Extended release dosage form |
| 09/22/2011 | US20110229532 Process for nanoemulsification of curcumin and derivatives of curcumin |
| 09/22/2011 | US20110229531 Anti-protozoa compounds |
| 09/22/2011 | US20110229530 Pharmaceutical dosage forms for time-specific drug delivery |
| 09/22/2011 | US20110229529 Lipid vesicle compositions and methods of use |
| 09/22/2011 | US20110229528 Pegylated polyplexes for polynucleotide delivery |
| 09/22/2011 | US20110229527 Directly compressible high functionality granular dibasic calcium phosphate based co-processed excipient |
| 09/22/2011 | US20110229526 Formulations of nonopioid and confined opioid analgesics |
| 09/22/2011 | US20110229418 Compositions and Methods of Treating and Preventing Lung Cancer |
| 09/22/2011 | US20110229417 Emollient Foams for Treatment of Seborrheic Dermatitis |
| 09/22/2011 | US20110229407 Alpha-Fetoprotein Immu31 Antibodies and Fusion Proteins and Methods of Use Thereof |
| 09/22/2011 | DE102008037025B4 Kristalline Wirkstoff-Mikropartikel, Verfahren zu deren Herstellung und Verwendung in Arzneimitteln Crystalline drug microparticles, methods for their preparation and use in medicaments |
| 09/22/2011 | CA2797295A1 Ganglioside micelles as a delivery system for hidrophobic drugs |
| 09/22/2011 | CA2793686A1 Pharmaceutical compositions comprising a pancreatic enzyme preparation with viral infectivity reduced below a significant level and methods of preparing and using the same |
| 09/22/2011 | CA2793685A1 Gastro-resistant enzyme pharmaceutical compositions |
| 09/22/2011 | CA2793604A1 Lipid vesicle compositions and methods of use |
| 09/22/2011 | CA2793525A1 Method for improving dissolution of anticoagulant agent |
| 09/22/2011 | CA2793302A1 Process of manufacturing a lyophilized fast dissolving, muti-phasic dosage form |
| 09/22/2011 | CA2793170A1 Aerosolized dapsone as a therapy for inflammation of the airway and abnormal mucociliary transport |
| 09/22/2011 | CA2792927A1 Proteoglycan-containing microneedle array |
| 09/22/2011 | CA2792764A1 Spray-pumpable composition suitable for topical skin application |
| 09/22/2011 | CA2792749A1 Composition for nasal administration and method for preparing it |
| 09/22/2011 | CA2792179A1 Heterogeneous implantable devices for drug delivery |
| 09/22/2011 | CA2788060A1 Pharmaceutical composition for treatment of increased intraocular pressure |
| 09/21/2011 | EP2366720A1 Low-substituted hydroxypropylcellulose and solid preparation comprising the same |
| 09/21/2011 | EP2366408A1 Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation |
| 09/21/2011 | EP2366401A1 Aqueous composition containing follicle-stimulating hormone |
| 09/21/2011 | EP2366400A1 Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine |
| 09/21/2011 | EP2366396A1 Myocardial perfusion imaging using adenosine receptor agonists |
| 09/21/2011 | EP2366395A1 Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis |
| 09/21/2011 | EP2366388A1 Non-occlusive transdermal therapeutic system for administering buprenorphine |
| 09/21/2011 | EP2366387A1 Ceramic matrix for incorporating controlled release drugs, a tablet, method for obtaining the ceramic matrix and method for producing a tablet |
| 09/21/2011 | EP2366386A1 Nanoparticulate systems prepared from anionic polymers |
| 09/21/2011 | EP2366385A1 Poly (lactide-co-glycolide)-based sustained release microcapsules comprising a polypeptide and a sugar |
| 09/21/2011 | EP2366384A2 Pharmaceutical formulation |
| 09/21/2011 | EP2366383A2 Pharmaceutical formulation |
| 09/21/2011 | EP2366382A2 Pharmaceutical formulation |
| 09/21/2011 | EP2366381A1 Phenylephrine pharmaceutical formulations and compositions for colonic absorption |
| 09/21/2011 | EP2366380A1 Extended release formulation containing a wax |
| 09/21/2011 | EP2366379A1 Cefdinir formulation with improved dissolution rate |
| 09/21/2011 | EP2366378A1 Sustained-release donepezil formulations |
| 09/21/2011 | EP2365908A2 Substrates providing multiple releases of active agents |
| 09/21/2011 | EP2365812A1 Pharmaceutical formulations for iontophoretic delivery of a corticosteroid |
| 09/21/2011 | EP2365803A1 Polyvalent rna-nanoparticle compositions |
| 09/21/2011 | EP2365802A2 Inhibition of mammalian target of rapamycin |
| 09/21/2011 | EP2365801A1 Melt-coated pharmaceutical composition with fast release |
| 09/21/2011 | EP2365800A2 Ulipristal acetate tablets |
| 09/21/2011 | EP2365799A1 Directly compressible high functionality granular dibasic calcium phosphate based co-processed excipient |
| 09/21/2011 | EP2365798A2 Wet granulation of tenofovir, emtricitabine and efavirenz |
| 09/21/2011 | EP2365797A1 Small interfering rna delivery |
| 09/21/2011 | EP2365796A1 Fusogenic properties of saposin c and related proteins and peptides for application to transmembrane drug delivery systems |
| 09/21/2011 | EP2278956B1 Antiviral formulation |
| 09/21/2011 | EP2242479B1 Counter-pressure filtration of proteins |
| 09/21/2011 | EP2101742B8 Pharmaceutical composition containing clopidogrel hydrogenesulphate of polymorph 1 form |
| 09/21/2011 | EP1965864B1 Composition of inverse emulsion type comprising ivermectin, and uses thereof in cosmetics and dermatology |
| 09/21/2011 | EP1957038B8 Particles |
| 09/21/2011 | EP1872796B1 Transdermal preparation for external use containing nonsteroidal antiinflammatory/analgesic agent |
| 09/21/2011 | EP1720551B9 Alkaloid formulations |
| 09/21/2011 | EP1684733B1 G i tract delivery systems |
| 09/21/2011 | EP1572240B1 Compositions, methods, and kits useful for the alleviation of gastrointestinal side effects of lipase inhibitors |
| 09/21/2011 | EP1553927B9 Gel-stabilized nanoparticulate active agent compositions |
| 09/21/2011 | EP1542556B1 Antimicrobial body covering articles |
| 09/21/2011 | EP1531873B1 Agent delivery particle |
| 09/21/2011 | EP1341546B1 Kyberdrug as autovaccines with immune-regulating effects |
| 09/21/2011 | EP0725791B1 Recombinant p53 adenovirus methods and compositions |
| 09/21/2011 | CN201978189U 护眼贴 Eye stickers |
| 09/21/2011 | CN1980627B Foamed cleaser with suspended particles therein, method of producing same and a dispenser therefore |
| 09/21/2011 | CN1943724B A Chinese traditional medicinal composition for treatment of migraine and its preparation method |
| 09/21/2011 | CN1923263B Traditional Chinese medicine composition, its preparing method and quality controlling means |
| 09/21/2011 | CN1919252B Medicine for treating cardiovascular and cerebrovascular disease |
| 09/21/2011 | CN1897924B Drug coating providing high drug loading and methods for providing same |
| 09/21/2011 | CN1879628B An in-vitro trichomonas vaginalis treating vaginal suppository and preparation method thereof |
| 09/21/2011 | CN1723984B Medicine for inducing cells to die, and its application |
| 09/21/2011 | CN1468089B Microparticles for delivery of the heterologous nucleic acids |
| 09/21/2011 | CN102196821A Topical composition comprising a combination of at least two penetration enhancing agents |
| 09/21/2011 | CN102196812A Anti-viral agent |
| 09/21/2011 | CN102196811A Stable tablet containing 4,5-epoxymorphinan derivative |
| 09/21/2011 | CN102196807A Water insoluble polymer: starch-based film coatings for colon targeting |
| 09/21/2011 | CN102196806A Water insoluble polymer: indigestible water-soluble polysaccharide film coatings for colon targeting |
| 09/21/2011 | CN102196805A Heat sterilised injectable composition of hyaluronic acid or one of the salts thereof, polyols and lidocaine |
| 09/21/2011 | CN102196724A Calicivirus inactivation method |
| 09/21/2011 | CN102188758A Preparation method for solid implantation catgut for treating spinal diseases |
| 09/21/2011 | CN102188717A Self-emulsifying doxorubicin nanometer medicament and preparation method thereof |